Comparison | Pooled SE | 95%CI | Tau-square P-value for hetero-geneity | Pooled SP | 95%CI | Tau-square P-value for hetero-geneity | ||
---|---|---|---|---|---|---|---|---|
RDT versus EIA only (n = 5) | 99% | 98% | 100% | <0.001 | 100% | 100% | 100% | <0.001 |
RDT versus NAT or Immunoblot (n = 13) | 93% | 91% | 95% | <0.001 | 98% | 97% | 99% | <0.001 |
RDT versus EIA, NAT or Immunoblot (n = 14) | 97% | 96% | 098% | <0.001 | 100% | 100% | 100% | <0.001 |
Oral RDT versus blood reference (n = 12) | 94% | 93% | 96% | <0.001 | 100% | 100% | 100% | <0.001 |
Sample type | ||||||||
 Blood samples (n = 45) | 98% | 97% | 98% | <0.001 | 98% | 98% | 99% |  |
 Oral samples (n = 12) | 94% | 93% | 96% | <0.001 | 100% | 100% | 100% | <0.001 |
Source population | ||||||||
 General screening (n = 17) | 95% | 94% | 96% | <0.001 | 99% | 98% | 99% | <0.001 |
 High risk population (n = 19) | 97% | 96% | 98% | <0.001 | 94% | 94% | 95% | <0.001 |
 Hospital patients (n = 16) | 97% | 96% | 98% | <0.001 | 100% | 100% | 100% | <0.001 |
Antibody and Antigen Combo testing (n = 6) | 86% | 79% | 94% | <0.001 | 99% | 98% | 100% | <0.001 |
Oral kits brand | Â | Â | Â | Â | Â | Â | 100% | Â |
 OraQuick (n = 8) | 98% | 97% | 99% | <0.001 | 100% | 100% | 100% | <0.001 |
 Other brands (n = 6) | 88% | 84% | 92% | <0.001 | 99% | 99% | 100% | <0.001 |